Personalized Medicine: Exploiting Druggable Vulnerabilities for KRAS-driven Lung Cancer

Oncoscience - United States
doi 10.18632/oncoscience.416
Full Text
Abstract

Available in full text

Date
Authors

Unknown

Publisher

Impact Journals, LLC

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy